Technical Articles

近20亿美元恒瑞授权默沙东!Lp(a)从“基因宿命”到“可治之症”
Merck Acquires $2 Billion Licensing Deal from Hengrui: Transforming Lp(a) from "Genetic Destiny" to "Treatable Disorder"
发布时间 2025-03-27
Lp(a), the abbreviated form of lipoprotein(a), represents a distinctive class of plasma lipoprotein. This macromolecular complex consists of apolipoprotein B-100 covalently linked to apolipoprotein(a) via a disulfide bond. While structurally analogous to low-density lipoprotein (LDL), Lp(a) possesses unique pathogenicity conferred by its characteristic multikringle-domain apolipoprotein(a) moiety.
View details
  • Cardiovascular
  • Lp(a)
  • recombinant protein
Total 1
  • 1
Go to